- Home
- DAVE vs ATRC Comparison
DAVE vs ATRC Comparison
Compare DAVE & ATRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAVE
- ATRC
- Stock Information
- Founded
- DAVE 2017
- ATRC 2000
- Country
- DAVE United States
- ATRC United States
- Employees
- DAVE N/A
- ATRC N/A
- Industry
- DAVE Retail: Computer Software & Peripheral Equipment
- ATRC Medical/Dental Instruments
- Sector
- DAVE Technology
- ATRC Health Care
- Exchange
- DAVE Nasdaq
- ATRC Nasdaq
- Market Cap
- DAVE 1.1B
- ATRC 1.1B
- IPO Year
- DAVE N/A
- ATRC 2005
- Fundamental
- Price
- DAVE $81.87
- ATRC $34.39
- Analyst Decision
- DAVE Strong Buy
- ATRC Strong Buy
- Analyst Count
- DAVE 6
- ATRC 9
- Target Price
- DAVE $96.50
- ATRC $41.78
- AVG Volume (30 Days)
- DAVE 449.4K
- ATRC 438.0K
- Earning Date
- DAVE 03-04-2025
- ATRC 02-13-2025
- Dividend Yield
- DAVE N/A
- ATRC N/A
- EPS Growth
- DAVE N/A
- ATRC N/A
- EPS
- DAVE 3.12
- ATRC N/A
- Revenue
- DAVE $319,355,000.00
- ATRC $447,573,000.00
- Revenue This Year
- DAVE $34.76
- ATRC $17.75
- Revenue Next Year
- DAVE $19.52
- ATRC $13.44
- P/E Ratio
- DAVE $26.25
- ATRC N/A
- Revenue Growth
- DAVE 30.00
- ATRC 17.56
- 52 Week Low
- DAVE $9.55
- ATRC $18.94
- 52 Week High
- DAVE $108.50
- ATRC $39.05
- Technical
- Relative Strength Index (RSI)
- DAVE 44.54
- ATRC 58.47
- Support Level
- DAVE $77.44
- ATRC $31.00
- Resistance Level
- DAVE $94.04
- ATRC $34.11
- Average True Range (ATR)
- DAVE 6.46
- ATRC 1.43
- MACD
- DAVE -2.11
- ATRC 0.40
- Stochastic Oscillator
- DAVE 17.67
- ATRC 95.36
About DAVE Dave Inc.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit, and finding side gigs.
About ATRC AtriCure Inc.
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation Pacing and Sensing, and others. The company also offers a variety of minimally invasive ablation devices and access tools to facilitate the growing trend in less invasive cardiac and thoracic surgery. Geographically, it generates a majority of its revenue from the United States.